Cardeas Pharma: Clinical Trials

3 trials sponsored by Cardeas Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 11Completed 1

Follow Cardeas Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers
amikacin/fosfomycin - Healthy
Phase 1CompletedCardeas Pharma302016-04-012016-07-11
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Amikacin Fosfomycin Inhalation Solution, Aerosolized placebo - Pneumonia, Bacterial
Phase 2WithdrawnCardeas Pharma2014-10-012015-11-18
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Amikacin fosfomycin inhalation solution, Aerosolized placebo - Pneumonia, Bacterial
Phase 2CompletedCardeas Pharma1432013-12-012017-07-02

Conditions studied

Bacterial Infections (2)  ·  Lung Diseases (2)  ·  Pneumonia (2)  ·  Pneumonia, Bacterial (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)

Interventions

Amikacin (1)  ·  Fosfomycin (1)

Countries

United States (2)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Bruce Montgomery, M.D. (1)  ·  Marin Kollef, M.D. (1)

Results publications

PMID 27890714